Related Experiment Video
Updated: Feb 16, 2026

16:49
Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
12.1K
Hepatitis C Virus: Viral Quasispecies and Genotypes
Kyoko Tsukiyama-Kohara1, Michinori Kohara2
1Joint Faculty of Veterinary Meedicine, Kagoshima University, 1-21-24 Korimoto Kagoshima-city, Kgoshima 890-0065, Japan. kkohara@vet.kagoshima-u.ac.jp.
International Journal of Molecular Sciences
|December 23, 2017
Summary
Hepatitis C virus (HCV) causes chronic liver disease and cancer. Newer direct-acting antivirals (DAAs) offer effective treatment for HCV genotypes, overcoming resistance challenges.
Area of Science:
- Hepatology and Virology
- Viral Pathogenesis and Treatment
Background:
- Hepatitis C virus (HCV) establishes persistent cytoplasmic infections, leading to severe liver conditions like cirrhosis and cancer.
- HCV's high mutation rate generates diverse viral quasispecies, classified by envelope and NS5A protein variations.
- HCV genotype 1 is globally prevalent, with genotype-specific responses to interferon therapy.
Purpose of the Study:
- To review the characteristics of Hepatitis C virus (HCV) infection.
- To discuss the evolution of HCV treatment strategies.
- To highlight the efficacy and resistance profiles of direct-acting antivirals (DAAs).
Main Methods:
- Literature review of HCV replication, genotypes, and treatment outcomes.
- Analysis of viral quasispecies formation and classification.
- Evaluation of direct-acting antiviral (DAA) mechanisms and resistance.
Main Results:
- HCV replicates in the cytoplasm, causing chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
- Viral quasispecies are formed due to high mutation rates, impacting treatment.
- Direct-acting antivirals (DAAs) demonstrate superior efficacy compared to older therapies.
- Recent DAAs exhibit broad pan-genomic activity and a higher resistance barrier.
Conclusions:
- HCV infection poses significant global health challenges due to its replication and mutation capabilities.
- Direct-acting antivirals (DAAs) represent a major advancement in HCV treatment, offering improved outcomes.
- Ongoing research focuses on overcoming DAA resistance and achieving sustained virologic response across all genotypes.
Related Concept Videos
Viral Recombination
25.2K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
25.2K
Viruses with RNA Genomes
981
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
981
Single Nucleotide Polymorphisms-SNPs
18.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.6K
Subviral Agents
596
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
596
Viral Mutations
40.0K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Size and Structure of Viral Genomes
844
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
844

